Parker Waichman LLP Headlines by Topic
Depakote
Danish Study Finds Depakote May Raise Autism Risk
Dec 7, 2011
| Parker Waichman LLP
Taking Depakote and other valproate drugs during pregnancy could make it more likely that a child will develop autism spectrum disorder (ASD),...
Abbott Preps for Depakote Marketing Settlement
Oct 20, 2011
| Parker Waichman LLP
The maker of Depakote has set aside $1.5 million to settle charges it illegally promoted off-label, or unapproved uses, of the anti-seizure...
Depakote, Other Valproate Medications in Pregnancy May Lower Child's IQ
Sep 6, 2011
| Parker Waichman LLP
Depakote and other forms of valproate medications could impact the cognitive ability of children if they are taken during pregnancy, according to a...
Lower IQ Scores Linked to Depakote during Pregnancy
Jul 1, 2011
| Parker Waichman LLP
More evidence has emerged linking fetal exposure to Depakote and similar epilepsy drugs to problems in children. According to a Drug Safety...
High Doses of Epilepsy Drugs Increase Birth Defect Risks
Jun 6, 2011
| Parker Waichman LLP
While four popular epilepsy drugs do increase risks for birth defects, a new study indicates those risks could be mitigated. The study,...
New Study Inconclusive on Topamax Birth Defect Risk
May 20, 2011
| Parker Waichman LLP
A study that offers reassurance to expectant mothers who take new epilepsy drugs unfortunately doesn’t provide much comfort to those taking...
Common Epilepsy Drug Ups Birth Defect Risk
Jun 10, 2010
| Parker Waichman LLP
Valproic acid and related epilepsy drugs sold under the names Depakote, Depakene, Depacon, and Stavzor, increased the risk of six different birth...
Epilepsy Drugs to Carry Suicide Warnings
Dec 17, 2008
| Parker Waichman LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced. The drugs subject to...
Epilepsy Drugs Targeted for Black Box Suicide Warning
Jul 8, 2008
| Parker Waichman LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...
New Suicide Warning for Epilepsy Drugs
Jun 12, 2008
| Parker Waichman LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior. The...
